Becton Dickinson (BDX) Liabilities and Shareholders Equity (2009 - 2026)
Becton Dickinson (BDX) reported Liabilities and Shareholders Equity of $50.8 billion for Q1 2026, down 6.67% year-over-year from $54.5 billion in Q1 2025, and down 7.31% on a QoQ basis from $54.8 billion in Q4 2025.
Becton Dickinson (BDX) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $50.8 billion in Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 6.67% year-over-year to $50.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $215.9 billion (down 2.75% YoY) and the FY2025 annual result came in at $55.3 billion, down 3.42% from the prior year.
- Liabilities and Shareholders Equity eased to $50.8 billion in Q1 2026 per BDX's latest filing, from $54.8 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $57.3 billion in Q3 2024 and bottomed at $50.8 billion in Q1 2026.
- The 5-year median for Liabilities and Shareholders Equity is $54.4 billion (2023), against an average of $54.0 billion.
- The widest annual swing landed in 2024, when Liabilities and Shareholders Equity advanced 8.54%; it then slipped 6.67% in 2026.
- Tracing BDX's Liabilities and Shareholders Equity over 5 years: stood at $53.1 billion in 2022, then slipped by 1.61% to $52.3 billion in 2023, then rose by 4.57% to $54.7 billion in 2024, then climbed by 0.32% to $54.8 billion in 2025, then declined by 7.31% to $50.8 billion in 2026.
- Per Business Quant, the three latest BDX Liabilities and Shareholders Equity figures stand at $50.8 billion (Q1 2026), $54.8 billion (Q4 2025), and $55.3 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 8.78 Bn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 4.11 Bn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 14.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 12.42 Bn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 6.31 Bn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 19.85 Bn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 5.10 Bn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn | 2.93 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.83 Bn |
| Dec 31, 2025 | 54.84 Bn |
| Sep 30, 2025 | 55.33 Bn |
| Jun 30, 2025 | 54.90 Bn |
| Mar 31, 2025 | 54.47 Bn |
| Dec 31, 2024 | 54.67 Bn |
| Sep 30, 2024 | 57.29 Bn |
| Jun 30, 2024 | 55.58 Bn |
| Mar 31, 2024 | 54.16 Bn |
| Dec 31, 2023 | 52.27 Bn |
| Sep 30, 2023 | 52.78 Bn |
| Jun 30, 2023 | 53.02 Bn |
| Mar 31, 2023 | 54.39 Bn |
| Dec 31, 2022 | 53.13 Bn |
| Sep 30, 2022 | 52.93 Bn |
| Jun 30, 2022 | 53.20 Bn |
| Mar 31, 2022 | 54.79 Bn |
| Dec 31, 2021 | 53.36 Bn |
| Sep 30, 2021 | 53.87 Bn |
| Jun 30, 2021 | 54.33 Bn |
| Mar 31, 2021 | 54.92 Bn |
| Dec 31, 2020 | 54.75 Bn |
| Sep 30, 2020 | 54.01 Bn |
| Jun 30, 2020 | 53.96 Bn |
| Mar 31, 2020 | 53.52 Bn |
| Dec 31, 2019 | 51.95 Bn |
| Sep 30, 2019 | 51.77 Bn |
| Jun 30, 2019 | 52.23 Bn |
| Mar 31, 2019 | 52.60 Bn |
| Dec 31, 2018 | 52.93 Bn |
| Sep 30, 2018 | 53.90 Bn |
| Jun 30, 2018 | 53.98 Bn |
| Mar 31, 2018 | 54.57 Bn |
| Dec 31, 2017 | 55.36 Bn |
| Sep 30, 2017 | 37.73 Bn |
| Jun 30, 2017 | 37.17 Bn |
| Mar 31, 2017 | 24.12 Bn |
| Dec 31, 2016 | 24.32 Bn |
| Sep 30, 2016 | 25.59 Bn |
| Jun 30, 2016 | 26.02 Bn |
| Mar 31, 2016 | 26.24 Bn |
| Dec 31, 2015 | 26.05 Bn |
| Sep 30, 2015 | 26.48 Bn |
| Jun 30, 2015 | 27.08 Bn |
| Mar 31, 2015 | 28.29 Bn |
| Dec 31, 2014 | 18.50 Bn |
| Sep 30, 2014 | 12.38 Bn |
| Jun 30, 2014 | 12.37 Bn |
| Mar 31, 2014 | 12.25 Bn |
| Dec 31, 2013 | 12.04 Bn |
| Sep 30, 2013 | 12.15 Bn |
| Jun 30, 2013 | 11.59 Bn |
| Mar 31, 2013 | 11.63 Bn |
| Dec 31, 2012 | 11.63 Bn |
| Sep 30, 2012 | 11.36 Bn |
| Dec 31, 2011 | 11.41 Bn |
| Sep 30, 2011 | 10.43 Bn |
| Jun 30, 2011 | 10.62 Bn |
| Mar 31, 2011 | 10.34 Bn |
| Dec 31, 2010 | 10.07 Bn |
| Sep 30, 2010 | 9.65 Bn |
| Jun 30, 2010 | 9.03 Bn |
| Mar 31, 2010 | 8.94 Bn |
| Dec 31, 2009 | 9.09 Bn |
| Sep 30, 2009 | 9.30 Bn |
| Jun 30, 2009 | 8.85 Bn |